[Comorbidity and multimorbidity for allergic diseases]

Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Jun 6;56(6):735-739. doi: 10.3760/cma.j.cn112150-20220312-00229.
[Article in Chinese]

Abstract

The prevalence of allergic diseases has gradually increased worldwide along with the development of industrialization, changes in environmental factors, adjustment of people's diet structure and increasing exposure to allergens. Allergic diseases have become an important challenge to global public health strategies. Meanwhile, the coexistence with allergic rhinitis, and(or) allergic asthma, and(or) atopic dermatitis and other allergic diseases in a single patient is becoming more and more prevalent. Allergic comorbidities and multimorbidities will inevitably increase the difficulty of treating and recovery, seriously affect patients' quality of life, and greatly increase the burden on social medical insurance. Understanding the underlying mechanisms of comorbidities and multimorbidities has both preventive and therapeutic significance. This article reviews the research progress of allergy comorbidity and multimorbidity in order to address the importance of this phenominon, stimulate clinical attention and provide a reference for the formulation of prevention and treatment strategies.

随着工业化进程的发展、环境因素的改变、人们饮食结构的调整及接触过敏原种类的不断增加,过敏性疾病的患病率在全世界范围内呈升高趋势,已经成为全球重要的公共卫生问题。与此同时,同一患者罹患过敏性鼻炎、过敏性哮喘、特应性皮炎等多种过敏性疾病的现象也越来越普遍,过敏性疾病的共病与多病使得病情更加复杂,严重影响患者生活质量、增加治疗难度、延长治疗周期、极大增加社会医疗负担。积极应对过敏性疾病共病与多病,研究其发病机制,制订相应的治疗指南,兼具预防及治疗意义。本文阐述了过敏性疾病共病与多病的相关研究进展,以引起临床关注,并为预防与治疗策略的制定提供参考。.

Publication types

  • Review

MeSH terms

  • Asthma* / epidemiology
  • Comorbidity
  • Humans
  • Multimorbidity
  • Quality of Life
  • Rhinitis, Allergic* / epidemiology